Biotechnology
The Biotechnology industry has a total of 592 stocks, with a combined market cap of $1.25 trillion and total revenue of $116.51 billion.
Market Cap
1.25T
Revenue
116.51B
Profits
-35.42B
PE Ratio
n/a
Profit Margin
-30.40%
Dividend Yield
0.04%
592 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals Incorporated | 128.95B | 2.06% | 2,262,513 | 12.59B |
| 2 | MRNA | Moderna, Inc. | 94.42B | 4.51% | 17,360,393 | 2.23B |
| 3 | REGN | Regeneron Pharmaceuticals, Inc. | 77.72B | 2.31% | 798,815 | 15.53B |
| 4 | ARGX | argenx SE | 53.15B | 3.42% | 510,744 | 5.32B |
| 5 | ONC | BeOne Medicines AG | 42.53B | 6.43% | 744,814 | 6.13B |
| 6 | RVMD | Revolution Medicines, Inc. | 40.57B | -2.20% | 1,568,318 | - |
| 7 | RPRX | Royalty Pharma plc | 34.28B | 1.07% | 3,407,011 | 2.54B |
| 8 | ALNY | Alnylam Pharmaceuticals, Inc. | 31.32B | 4.26% | 1,257,389 | 4.80B |
| 9 | ROIV | Roivant Sciences Ltd. | 24.59B | 1.25% | 4,565,910 | 7.53M |
| 10 | INCY | Incyte Corporation | 22.96B | 1.52% | 1,940,492 | 5.82B |
| 11 | BNTX | BioNTech SE | 22.66B | 1.74% | 1,079,902 | 3.03B |
| 12 | GMAB | Genmab A/S | 22.65B | 2.52% | 4,084,403 | 4.13B |
| 13 | INSM | Insmed Incorporated | 21.67B | 1.45% | 3,346,590 | 1.14B |
| 14 | EXEL | Exelixis, Inc. | 15.57B | 3.02% | 2,774,090 | 2.44B |
| 15 | ASND | Ascendis Pharma A/S | 14.88B | -0.17% | 403,965 | 1.20B |
| 16 | JAZZ | Jazz Pharmaceuticals plc | 13.92B | 2.28% | 886,415 | 4.60B |
| 17 | HALO | Halozyme Therapeutics, Inc. | 13.79B | 4.01% | 2,470,003 | 1.66B |
| 18 | BBIO | BridgeBio Pharma, Inc. | 13.12B | 3.37% | 2,638,802 | 713.07M |
| 19 | SMMT | Summit Therapeutics Inc. | 12.29B | 1.59% | 996,521 | - |
| 20 | CORT | Corcept Therapeutics Incorporated | 12.26B | -2.46% | 668,355 | 830.81M |
| 21 | TECH | Bio-Techne Corporation | 11.37B | 0.03% | 2,403,822 | 1.22B |
| 22 | BMRN | BioMarin Pharmaceutical Inc. | 10.85B | 1.65% | 2,922,494 | 3.41B |
| 23 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.62B | -0.04% | 266,162 | 1.28B |
| 24 | IBRX | ImmunityBio, Inc. | 10.60B | 0.91% | 2,975,010 | 165.79M |
| 25 | PCVX | Vaxcyte, Inc. | 10.27B | -3.38% | 2,448,336 | - |
| 26 | KRYS | Krystal Biotech, Inc. | 9.77B | -0.21% | 288,017 | 440.48M |
| 27 | TWST | Twist Bioscience Corporation | 9.06B | -2.48% | 3,542,663 | 431.80M |
| 28 | KYMR | Kymera Therapeutics, Inc. | 8.99B | 1.23% | 820,991 | 105.00M |
| 29 | CAI | Caris Life Sciences, Inc. | 8.98B | 4.97% | 3,554,204 | 989.61M |
| 30 | CYTK | Cytokinetics, Incorporated | 8.89B | 0.77% | 1,665,140 | 67.67M |
| 31 | PTGX | Protagonist Therapeutics, Inc. | 8.84B | 0.20% | 707,725 | 281.99M |
| 32 | AXSM | Axsome Therapeutics, Inc. | 8.47B | -0.27% | 802,585 | 776.57M |
| 33 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.26B | 0.22% | 2,009,561 | 669.50M |
| 34 | ABVX | ABIVAX Société Anonyme | 8.00B | 5.00% | 1,520,153 | 5.33M |
| 35 | TGTX | TG Therapeutics, Inc. | 7.94B | 3.00% | 1,808,489 | 799.54M |
| 36 | SYRE | Spyre Therapeutics, Inc. | 7.49B | 1.87% | 1,148,026 | - |
| 37 | IONS | Ionis Pharmaceuticals, Inc. | 7.33B | 3.33% | 2,529,489 | 874.09M |
| 38 | PRAX | Praxis Precision Medicines, Inc. | 6.93B | 3.86% | 632,938 | 7.46M |
| 39 | IOVA | Iovance Biotherapeutics, Inc. | 6.67B | 3.59% | 11,510,406 | 324.97M |
| 40 | BLTE | Belite Bio, Inc | 6.15B | -0.07% | 195,857 | - |
| 41 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.06B | 1.45% | 644,561 | 239.92M |
| 42 | LGND | Ligand Pharmaceuticals Incorporated | 5.95B | 1.19% | 332,108 | 290.54M |
| 43 | IMVT | Immunovant, Inc. | 5.68B | -1.40% | 1,649,270 | - |
| 44 | KOD | Kodiak Sciences Inc. | 5.53B | 8.67% | 1,395,290 | - |
| 45 | CGON | CG Oncology, Inc. | 5.49B | 0.15% | 1,186,400 | 6.23M |
| 46 | MIRM | Mirum Pharmaceuticals, Inc. | 5.35B | 3.04% | 605,245 | 618.07M |
| 47 | ERAS | Erasca, Inc. | 5.20B | 1.16% | 8,481,000 | - |
| 48 | COGT | Cogent Biosciences, Inc. | 5.12B | 4.83% | 3,039,760 | - |
| 49 | PTCT | PTC Therapeutics, Inc. | 5.09B | 2.21% | 1,051,889 | 1.01B |
| 50 | CRSP | CRISPR Therapeutics AG | 4.98B | 2.59% | 1,351,150 | 13.39M |
| 51 | TVTX | Travere Therapeutics, Inc. | 4.98B | -0.90% | 1,980,593 | 591.33M |
| 52 | SRRK | Scholar Rock Holding Corporation | 4.95B | 2.63% | 1,944,684 | - |
| 53 | ORKA | Oruka Therapeutics, Inc. | 4.89B | -3.66% | 1,222,105 | - |
| 54 | MANE | Veradermics, Incorporated | 4.81B | 1.41% | 689,001 | - |
| 55 | DFTX | Definium Therapeutics, Inc. | 4.60B | 0.06% | 1,740,496 | - |
| 56 | DNTH | Dianthus Therapeutics, Inc. | 4.16B | -0.49% | 943,572 | 1.90M |
| 57 | EWTX | Edgewise Therapeutics, Inc. | 4.15B | 3.19% | 1,837,465 | - |
| 58 | ABCL | AbCellera Biologics Inc. | 4.11B | 2.51% | 982,581 | 66.17M |
| 59 | LEGN | Legend Biotech Corporation | 3.84B | 3.99% | 1,574,416 | 1.27B |
| 60 | TNGX | Tango Therapeutics, Inc. | 3.83B | 2.30% | 2,903,874 | 53.81M |
| 61 | RLAY | Relay Therapeutics, Inc. | 3.79B | 1.41% | 2,117,110 | 10.35M |
| 62 | ARQT | Arcutis Biotherapeutics, Inc. | 3.66B | 10.19% | 3,955,456 | 463.98M |
| 63 | TLX | Telix Pharmaceuticals Limited | 3.55B | -0.75% | 58,657 | 890.79M |
| 64 | ACAD | Acadia Pharmaceuticals Inc. | 3.40B | 2.39% | 333,129 | 1.14B |
| 65 | XENE | Xenon Pharmaceuticals Inc. | 3.32B | 1.27% | 1,617,856 | 7.50M |
| 66 | IDYA | IDEAYA Biosciences, Inc. | 3.27B | -0.03% | 1,341,844 | 234.13M |
| 67 | VKTX | Viking Therapeutics, Inc. | 3.19B | 7.46% | 5,224,078 | - |
| 68 | TARS | Tarsus Pharmaceuticals, Inc. | 3.12B | -1.80% | 1,407,351 | 606.33M |
| 69 | PBLS | Parabilis Medicines, Inc. | 3.11B | -2.74% | 955,212 | 148.00K |
| 70 | CELC | Celcuity Inc. | 2.95B | 0.67% | 2,123,433 | - |
| 71 | DNLI | Denali Therapeutics Inc. | 2.93B | 2.63% | 1,565,967 | 3.60M |
| 72 | RCUS | Arcus Biosciences, Inc. | 2.91B | 1.29% | 195,072 | 117.00M |
| 73 | ELVN | Enliven Therapeutics, Inc. | 2.88B | 0.13% | 2,053,726 | - |
| 74 | DYN | Dyne Therapeutics, Inc. | 2.86B | 1.73% | 2,074,625 | - |
| 75 | NRIX | Nurix Therapeutics, Inc. | 2.73B | 5.41% | 920,966 | 701.94M |
| 76 | ZLAB | Zai Lab Limited | 2.64B | 4.49% | 823,985 | 449.61M |
| 77 | PGEN | Precigen, Inc. | 2.58B | -2.18% | 3,952,551 | 85.72M |
| 78 | BEAM | Beam Therapeutics Inc. | 2.47B | 4.57% | 1,779,506 | 156.04M |
| 79 | NAMS | NewAmsterdam Pharma Company N.V. | 2.46B | 3.05% | 881,932 | 7.12M |
| 80 | MBX | MBX Biosciences, Inc. | 2.44B | 3.87% | 601,765 | - |
| 81 | ADMA | ADMA Biologics, Inc. | 2.40B | 3.77% | 2,772,372 | 512.28M |
| 82 | SLS | SELLAS Life Sciences Group, Inc. | 2.29B | -4.55% | 4,655,117 | - |
| 83 | CLDX | Celldex Therapeutics, Inc. | 2.27B | 3.93% | 1,181,692 | 158.00K |
| 84 | RXRX | Recursion Pharmaceuticals, Inc. | 2.23B | 11.23% | 61,179,932 | 54.86M |
| 85 | HRMY | Harmony Biosciences Holdings, Inc. | 2.23B | 2.03% | 798,332 | 959.90M |
| 86 | AUPH | Aurinia Pharmaceuticals Inc. | 2.23B | 0.72% | 1,031,787 | 311.51M |
| 87 | VRDN | Viridian Therapeutics, Inc. | 2.22B | 6.42% | 2,167,909 | 71.13M |
| 88 | IRON | Disc Medicine, Inc. | 2.17B | 1.63% | 699,762 | - |
| 89 | FTRE | Fortrea Holdings Inc. | 2.16B | 6.58% | 2,910,262 | 2.68B |
| 90 | NVAX | Novavax, Inc. | 2.11B | 1.42% | 7,366,328 | 413.80M |
| 91 | VCEL | Vericel Corporation | 2.10B | 1.91% | 601,206 | 306.30M |
| 92 | PHVS | Pharvaris N.V. | 2.08B | -1.27% | 820,419 | - |
| 93 | VERA | Vera Therapeutics, Inc. | 2.06B | 6.84% | 1,526,516 | - |
| 94 | ADRX | ADARx Pharmaceuticals, Inc. | 1.98B | -0.73% | 283,370 | 6.13M |
| 95 | IMNM | Immunome, Inc. | 1.98B | 1.16% | 1,621,123 | 4.02M |
| 96 | AGIO | Agios Pharmaceuticals, Inc. | 1.93B | 4.36% | 2,048,348 | 98.34M |
| 97 | LKFT | Lakefront Biotherapeutics NV | 1.93B | 1.67% | 227,152 | 1.13B |
| 98 | MLYS | Mineralys Therapeutics, Inc. | 1.91B | 4.24% | 1,093,902 | - |
| 99 | SRPT | Sarepta Therapeutics, Inc. | 1.88B | 5.70% | 4,041,898 | 1.97B |
| 100 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.84B | 7.94% | 2,367,226 | 208.78M |
| 101 | PVLA | Palvella Therapeutics, Inc. | 1.83B | 3.88% | 240,596 | - |
| 102 | ZYME | Zymeworks Inc. | 1.83B | 3.96% | 751,931 | 37.13M |
| 103 | URGN | UroGen Pharma Ltd. | 1.79B | 0.08% | 636,573 | 188.73M |
| 104 | XNCR | Xencor, Inc. | 1.78B | 2.61% | 726,917 | 104.97M |
| 105 | VIR | Vir Biotechnology, Inc. | 1.77B | 0.58% | 1,417,856 | 303.23M |
| 106 | MESO | Mesoblast Limited | 1.76B | 1.16% | 30,880 | 120.25M |
| 107 | SEPN | Septerna, Inc. | 1.75B | 3.11% | 271,437 | 98.88M |
| 108 | BHVN | Biohaven Ltd. | 1.73B | 4.57% | 1,448,269 | - |
| 109 | TRVI | Trevi Therapeutics, Inc. | 1.73B | 0.41% | 1,709,231 | - |
| 110 | GENB | Generate Biomedicines, Inc. | 1.68B | 4.31% | 974,901 | 26.48M |
| 111 | NUVB | Nuvation Bio Inc. | 1.67B | 1.50% | 4,822,968 | 169.90M |
| 112 | ZBIO | Zenas BioPharma, Inc. | 1.66B | 2.17% | 471,886 | 1.00M |
| 113 | OCUL | Ocular Therapeutix, Inc. | 1.62B | 2.50% | 3,251,884 | 52.06M |
| 114 | BRVE | Braveheart Bio, Inc. | 1.60B | 1.09% | 206,064 | - |
| 115 | NTLA | Intellia Therapeutics, Inc. | 1.59B | -0.79% | 4,684,993 | 59.51M |
| 116 | STOK | Stoke Therapeutics, Inc. | 1.59B | 5.80% | 818,173 | 27.59M |
| 117 | GPCR | Structure Therapeutics Inc. | 1.58B | 1.42% | 1,414,109 | - |
| 118 | QURE | uniQure N.V. | 1.56B | 7.39% | 1,373,824 | 18.67M |
| 119 | KRSA | Korsana Biosciences, Inc. | 1.54B | -1.54% | 176,034 | - |
| 120 | MAZE | Maze Therapeutics, Inc. | 1.53B | 4.77% | 539,300 | 20.00M |
| 121 | ABSI | Absci Corporation | 1.52B | 1.60% | 3,088,915 | 1.56M |
| 122 | COAG | Hemab Therapeutics Holdings, Inc. | 1.52B | 8.62% | 478,279 | - |
| 123 | IMCR | Immunocore Holdings plc | 1.52B | 4.02% | 378,197 | 430.78M |
| 124 | KLRA | Kailera Therapeutics, Inc. | 1.52B | 9.03% | 1,174,494 | - |
| 125 | INVA | Innoviva, Inc. | 1.51B | -0.52% | 672,982 | 440.00M |
| 126 | RARE | Ultragenyx Pharmaceutical Inc. | 1.49B | 1.81% | 3,331,965 | 717.00M |
| 127 | ANAB | AnaptysBio, Inc. | 1.46B | 4.37% | 416,303 | 106.09M |
| 128 | RAPP | Rapport Therapeutics, Inc. | 1.42B | 4.38% | 92,890 | 20.00M |
| 129 | OMER | Omeros Corporation | 1.36B | 1.95% | 931,363 | 38.42M |
| 130 | INBX | Inhibrx Biosciences, Inc. | 1.33B | 6.15% | 226,372 | 1.30M |
| 131 | ORIC | ORIC Pharmaceuticals, Inc. | 1.32B | 10.18% | 557,726 | - |
| 132 | AAPG | Ascentage Pharma Group International | 1.31B | -1.08% | 8,957 | 94.61M |
| 133 | TYRA | Tyra Biosciences, Inc. | 1.31B | 1.82% | 418,027 | - |
| 134 | KARD | Kardigan, Inc. | 1.30B | 2.51% | 660,929 | - |
| 135 | GHRS | GH Research PLC | 1.29B | 1.35% | 276,719 | - |
| 136 | NKTR | Nektar Therapeutics | 1.29B | 2.25% | 684,207 | 54.59M |
| 137 | TRAX | First Tracks Biotherapeutics, Inc. | 1.29B | 5.60% | 1,466,746 | - |
| 138 | SNDX | Syndax Pharmaceuticals, Inc. | 1.22B | 0.89% | 2,626,197 | 252.25M |
| 139 | TSHA | Taysha Gene Therapies, Inc. | 1.22B | 6.27% | 4,685,718 | 5.49M |
| 140 | DRTS | Alpha Tau Medical Ltd. | 1.22B | -2.52% | 620,180 | - |
| 141 | SVRA | Savara Inc. | 1.20B | -0.42% | 1,691,413 | - |
| 142 | LBRX | LB Pharmaceuticals Inc | 1.18B | 7.97% | 976,644 | - |
| 143 | BCAX | Bicara Therapeutics Inc. | 1.17B | 1.61% | 662,061 | - |
| 144 | DMRA | Damora Therapeutics, Inc. | 1.16B | 1.68% | 357,623 | - |
| 145 | VOR | Vor Biopharma Inc. | 1.14B | 3.15% | 696,515 | - |
| 146 | NBTX | Nanobiotix S.A. | 1.12B | 4.46% | 116,354 | 13.15M |
| 147 | VSTM | Verastem, Inc. | 1.12B | 19.71% | 16,951,724 | 87.53M |
| 148 | REPL | Replimune Group, Inc. | 1.11B | 3.16% | 1,613,633 | - |
| 149 | AVLN | Avalyn Pharma Inc. | 1.09B | 4.01% | 199,362 | - |
| 150 | JANX | Janux Therapeutics, Inc. | 1.06B | 1.11% | 546,896 | 24.00M |
| 151 | MNKD | MannKind Corporation | 1.03B | 5.63% | 3,756,527 | 393.63M |
| 152 | LTGO | Latigo Biotherapeutics, Inc. | 978.58M | 5.43% | 242,898 | - |
| 153 | IMTX | Immatics N.V. | 975.97M | 2.00% | 1,629,202 | 47.65M |
| 154 | MGTX | MeiraGTx Holdings plc | 948.90M | 4.99% | 836,396 | 397.50M |
| 155 | SPTX | Seaport Therapeutics, Inc. | 943.74M | 5.70% | 164,841 | - |
| 156 | CGEM | Cullinan Therapeutics, Inc. | 900.97M | 2.64% | 972,108 | - |
| 157 | IAM | Iambic Therapeutics, Inc. | 896.35M | 113.43% | 438,427 | 18.25M |
| 158 | AKTS | Aktis Oncology, Inc. | 890.47M | -2.91% | 667,740 | 10.06M |
| 159 | ANRO | Alto Neuroscience, Inc. | 887.66M | 4.19% | 162,557 | - |
| 160 | SLBT | SL Science Holding Limited | 883.91M | - | 130,671 | 3.27M |
| 161 | RIGL | Rigel Pharmaceuticals, Inc. | 882.62M | 0.92% | 167,848 | 276.79M |
| 162 | JBIO | Jade Biosciences, Inc. | 875.10M | 2.38% | 1,038,873 | - |
| 163 | MLTX | MoonLake Immunotherapeutics | 873.19M | 1.18% | 1,067,221 | - |
| 164 | GLUE | Monte Rosa Therapeutics, Inc. | 863.37M | 2.85% | 1,543,913 | 28.73M |
| 165 | KURA | Kura Oncology, Inc. | 862.92M | 0.94% | 1,676,651 | 77.23M |
| 166 | ABUS | Arbutus Biopharma Corporation | 848.77M | 2.39% | 2,276,548 | 181.72M |
| 167 | ODTX | Odyssey Therapeutics, Inc. | 841.93M | 5.84% | 159,238 | 99.00K |
| 168 | CRVS | Corvus Pharmaceuticals, Inc. | 828.59M | 5.01% | 1,000,121 | - |
| 169 | AVBP | ArriVent BioPharma, Inc. | 827.88M | 3.64% | 815,702 | - |
| 170 | SGP | SpyGlass Pharma, Inc. | 826.83M | 4.35% | 47,119 | - |
| 171 | ALMS | Alumis Inc. | 816.74M | 4.13% | 2,786,513 | 7.40M |
| 172 | ARDX | Ardelyx, Inc. | 814.84M | 2.51% | 4,065,832 | 450.89M |
| 173 | HELP | Helus Pharma Inc. | 807.31M | 6.45% | 1,521,604 | - |
| 174 | DNA | Ginkgo Bioworks Holdings, Inc. | 791.92M | 1.99% | 2,330,098 | 132.42M |
| 175 | GERN | Geron Corporation | 790.24M | 3.36% | 5,678,416 | 204.56M |
| 176 | ANL | Adlai Nortye Group Ltd. | 778.57M | 11.12% | 864,143 | 18.06M |
| 177 | APMD | Apnimed, Inc. | 759.55M | 5.89% | 260,218 | 115.12M |
| 178 | OBX | Obsidian Therapeutics, Inc. | 753.63M | -0.16% | 240,297 | - |
| 179 | IVA | Inventiva S.A. | 750.45M | 8.36% | 2,906,402 | 2.81M |
| 180 | SANA | Sana Biotechnology, Inc. | 740.92M | 6.22% | 2,916,124 | - |
| 181 | LXRX | Lexicon Pharmaceuticals, Inc. | 734.18M | 3.12% | 1,433,567 | 41.47M |
| 182 | IMMX | Immix Biopharma, Inc. | 719.60M | 2.00% | 1,314,377 | - |
| 183 | ACHV | Achieve Life Sciences, Inc. | 717.23M | -0.43% | 1,197,726 | - |
| 184 | FDMT | 4D Molecular Therapeutics, Inc. | 710.99M | 5.49% | 787,560 | 92.01M |
| 185 | OABI | OmniAb, Inc. | 687.70M | 3.96% | 820,686 | 38.46M |
| 186 | PHAR | Pharming Group N.V. | 683.83M | -0.10% | 7,341 | 366.48M |
| 187 | MDXG | MiMedx Group, Inc. | 683.62M | -0.21% | 1,331,062 | 355.17M |
| 188 | ANNX | Annexon, Inc. | 682.48M | -1.91% | 2,653,845 | - |
| 189 | CADL | Candel Therapeutics, Inc. | 681.78M | -1.76% | 989,312 | - |
| 190 | GYRE | Gyre Therapeutics, Inc. | 678.62M | -1.08% | 108,762 | 109.82M |
| 191 | ATTO | Attovia Therapeutics, Inc. | 676.32M | -0.97% | 641,397 | 1.80M |
| 192 | AURA | Aura Biosciences, Inc. | 657.49M | 2.76% | 604,521 | - |
| 193 | DSGN | Design Therapeutics, Inc. | 655.86M | 7.71% | 131,844 | - |
| 194 | AVTX | Avalo Therapeutics, Inc. | 644.10M | 1.44% | 936,784 | 59.00K |
| 195 | PRME | Prime Medicine, Inc. | 642.23M | 15.34% | 6,293,796 | 4.07M |
| 196 | WVE | Wave Life Sciences, Inc. | 628.58M | 3.24% | 3,350,887 | 65.37M |
| 197 | CLYM | Climb Bio, Inc. | 626.63M | 6.03% | 515,480 | - |
| 198 | NVCT | Nuvectis Pharma, Inc. | 616.77M | 5.17% | 156,861 | - |
| 199 | SLDB | Solid Biosciences Inc. | 615.47M | 5.03% | 2,033,369 | - |
| 200 | ZVRA | Zevra Therapeutics, Inc. | 609.87M | 0.39% | 462,444 | 136.07M |
| 201 | OLMA | Olema Pharmaceuticals, Inc. | 601.11M | 1.03% | 1,088,435 | - |
| 202 | PHAT | Phathom Pharmaceuticals, Inc. | 595.73M | 1.35% | 1,210,168 | 239.66M |
| 203 | CRMD | CorMedix Inc. | 581.46M | 0.95% | 1,466,190 | 462.25M |
| 204 | SGMT | Sagimet Biosciences Inc. | 579.32M | 8.28% | 1,366,994 | - |
| 205 | VALN | Valneva SE | 573.48M | 4.42% | 8,655 | 163.30M |
| 206 | SLN | Silence Therapeutics plc | 562.96M | 4.12% | 2,567,485 | 615.00K |
| 207 | STTK | Shattuck Labs, Inc. | 555.01M | 3.75% | 867,810 | 1.00M |
| 208 | DBVT | DBV Technologies S.A. | 552.62M | 2.71% | 432,283 | 5.04M |
| 209 | ETRA | Electra Therapeutics, Inc. | 549.21M | -2.13% | 179,539 | - |
| 210 | PBYI | Puma Biotechnology, Inc. | 543.04M | 3.14% | 377,412 | 231.24M |
| 211 | CBIO | Crescent Biopharma, Inc. | 534.16M | -0.79% | 294,952 | 11.88M |
| 212 | FTH | Faeth Therapeutics, Inc. | 532.31M | 3.00% | 231,649 | - |
| 213 | CTMX | CytomX Therapeutics, Inc. | 525.14M | 8.07% | 2,631,689 | 18.30M |
| 214 | DRUG | Bright Minds Biosciences Inc. | 524.39M | 6.90% | 121,449 | - |
| 215 | ACRS | Aclaris Therapeutics, Inc. | 513.72M | 3.25% | 2,587,372 | 8.22M |
| 216 | MNPR | Monopar Therapeutics Inc. | 481.93M | -1.78% | 31,170 | - |
| 217 | ENTX | Entera Bio Ltd. | 481.77M | 10.80% | 1,447,710 | 42.00K |
| 218 | NGNE | Neurogene Inc. | 479.27M | 7.98% | 587,982 | 925.00K |
| 219 | YDES | YD Bio Limited | 477.40M | 5.97% | 72,321 | 1.24M |
| 220 | BLSM | BlossomHill Therapeutics, Inc. | 475.50M | -1.97% | 176,511 | - |
| 221 | RGNX | REGENXBIO Inc. | 472.65M | 4.07% | 435,168 | 174.48M |
| 222 | ARVN | Arvinas, Inc. | 468.17M | 4.99% | 604,841 | 316.70M |
| 223 | ALLO | Allogene Therapeutics, Inc. | 462.96M | 3.08% | 4,515,139 | 4.64M |
| 224 | ALT | Altimmune, Inc. | 459.06M | 2.16% | 535,706 | 31.00K |
| 225 | AUTL | Autolus Therapeutics plc | 457.80M | 1.78% | 1,486,108 | 117.39M |
| 226 | OCS | Oculis Holding AG | 456.82M | 3.21% | 559,160 | 1.45M |
| 227 | EPRX | Eupraxia Pharmaceuticals Inc. | 447.05M | 2.73% | 297,259 | - |
| 228 | MPLT | MapLight Therapeutics, Inc. | 445.72M | 2.69% | 658,421 | - |
| 229 | OVID | Ovid Therapeutics Inc. | 441.37M | 3.20% | 1,333,228 | 1.58M |
| 230 | PROK | ProKidney Corp. | 439.88M | -1.02% | 1,108,959 | 818.00K |
| 231 | PRTA | Prothena Corporation plc | 436.36M | 1.55% | 358,336 | 54.53M |
| 232 | DMAC | DiaMedica Therapeutics Inc. | 433.56M | 4.96% | 303,894 | - |
| 233 | CAPR | Capricor Therapeutics, Inc. | 422.67M | 10.32% | 3,354,963 | 11.13M |
| 234 | ASMB | Assembly Biosciences, Inc. | 418.82M | 0.19% | 204,161 | 74.85M |
| 235 | TECX | Tectonic Therapeutic, Inc. | 416.40M | 1.62% | 187,390 | - |
| 236 | AGMB | AgomAb Therapeutics NV | 410.24M | -4.14% | 90,912 | - |
| 237 | ZURA | Zura Bio Limited | 410.15M | -2.95% | 4,995,820 | - |
| 238 | RZLT | Rezolute, Inc. | 409.10M | -7.80% | 2,120,174 | - |
| 239 | EIKN | Eikon Therapeutics, Inc. | 408.40M | 7.56% | 657,042 | - |
| 240 | SPRY | ARS Pharmaceuticals, Inc. | 404.75M | 3.56% | 2,220,029 | 116.93M |
| 241 | SCTX | Scribe Therapeutics Inc. | 392.26M | -0.24% | 180,843 | 33.30M |
| 242 | TRXB | TRex Bio, Inc. | 381.22M | 4.89% | 88,625 | - |
| 243 | INDP | Indaptus Therapeutics, Inc. | 379.74M | 28.96% | 1,326,342 | - |
| 244 | EDIT | Editas Medicine, Inc. | 374.74M | 7.49% | 1,858,481 | 47.01M |
| 245 | GALT | Galectin Therapeutics Inc. | 374.15M | 1.92% | 119,182 | - |
| 246 | KYTX | Kyverna Therapeutics, Inc. | 369.21M | 5.01% | 779,414 | - |
| 247 | AVIR | Atea Pharmaceuticals, Inc. | 363.33M | -2.16% | 319,365 | - |
| 248 | FENC | Fennec Pharmaceuticals Inc. | 362.95M | 3.71% | 112,304 | 59.22M |
| 249 | TTRX | Turn Therapeutics Inc. | 345.24M | 4.32% | 80,339 | - |
| 250 | OBIO | Orchestra BioMed Holdings, Inc. | 345.00M | 1.77% | 253,378 | 31.98M |
| 251 | VTVT | vTv Therapeutics Inc. | 342.80M | 0.25% | 22,239 | 36.84M |
| 252 | CCCC | C4 Therapeutics, Inc. | 342.01M | 6.51% | 829,301 | 35.04M |
| 253 | PRLD | Prelude Therapeutics Incorporated | 341.94M | 2.79% | 400,242 | 22.42M |
| 254 | RLMD | Relmada Therapeutics, Inc. | 341.34M | -1.23% | 909,041 | - |
| 255 | IRD | Opus Genetics, Inc. | 336.94M | -1.22% | 2,902,082 | 9.86M |
| 256 | ENTA | Enanta Pharmaceuticals, Inc. | 334.07M | 2.59% | 178,425 | 65.26M |
| 257 | IKT | Inhibikase Therapeutics, Inc. | 333.20M | 1.67% | 401,740 | 1.00 |
| 258 | ARCT | Arcturus Therapeutics Holdings Inc. | 320.33M | 1.35% | 493,345 | 29.37M |
| 259 | AGEN | Agenus Inc. | 300.74M | 2.77% | 815,424 | 132.69M |
| 260 | CTNM | Contineum Therapeutics, Inc. | 297.21M | -2.95% | 280,620 | - |
| 261 | ARTV | Artiva Biotherapeutics, Inc. | 296.27M | 2.54% | 478,234 | 251.00K |
| 262 | BNTC | Benitec Biopharma Inc. | 295.11M | 2.05% | 153,730 | - |
| 263 | SRZN | Surrozen, Inc. | 294.66M | 5.56% | 363,793 | 11.51M |
| 264 | FULC | Fulcrum Therapeutics, Inc. | 280.01M | - | 1,225,821 | 80.00M |
| 265 | OCGN | Ocugen, Inc. | 275.93M | -3.27% | 1,113,238 | 4.58M |
| 266 | NAUT | Nautilus Biotechnology, Inc. | 274.87M | - | 8,634,710 | 190.00K |
| 267 | IPSC | Century Therapeutics, Inc. | 271.61M | 8.70% | 927,158 | 109.16M |
| 268 | EYPT | EyePoint, Inc. | 270.71M | 4.32% | 2,835,642 | 2.79M |
| 269 | PALI | Palisade Bio, Inc. | 268.38M | 4.05% | 1,817,613 | 500.00K |
| 270 | ABEO | Abeona Therapeutics Inc. | 265.91M | 6.65% | 1,377,233 | 25.52M |
| 271 | CABA | Cabaletta Bio, Inc. | 262.80M | -4.32% | 6,741,616 | - |
| 272 | XFOR | X4 Pharmaceuticals, Inc. | 261.75M | 7.76% | 549,491 | 15.85M |
| 273 | RCKT | Rocket Pharmaceuticals, Inc. | 259.07M | 6.79% | 1,878,183 | - |
| 274 | VNDA | Vanda Pharmaceuticals Inc. | 256.36M | 0.47% | 1,046,457 | 215.72M |
| 275 | VCRE | Vicore Pharma Holding AB (publ) | 251.99M | 0.11% | 38,514 | 412.09K |
| 276 | BCYC | Bicycle Therapeutics plc | 251.97M | 2.56% | 411,542 | 61.21M |
| 277 | LCTX | Lineage Cell Therapeutics, Inc. | 250.45M | 7.93% | 1,424,511 | 13.08M |
| 278 | CUVL | Clinuvel Pharmaceuticals Limited | 243.84M | -4.53% | 3,387 | 65.05M |
| 279 | ACIU | AC Immune SA | 243.60M | 2.08% | 86,886 | 21.67M |
| 280 | VOGX | Vogenx, Inc. | 238.42M | -0.31% | 186,620 | - |
| 281 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 236.51M | 1.55% | 473,893 | - |
| 282 | SABS | SAB Biotherapeutics, Inc. | 235.65M | 4.02% | 787,910 | 114.70K |
| 283 | IMRX | Immuneering Corporation | 235.50M | 6.43% | 934,283 | - |
| 284 | QTTB | Q32 Bio Inc. | 231.31M | -3.00% | 624,986 | 53.74M |
| 285 | FATE | Fate Therapeutics, Inc. | 230.65M | -0.77% | 1,157,825 | 6.49M |
| 286 | LXEO | Lexeo Therapeutics, Inc. | 226.44M | 4.94% | 1,303,784 | - |
| 287 | GLSI | Greenwich LifeSciences, Inc. | 224.87M | -0.52% | 81,348 | - |
| 288 | SLGL | Sol-Gel Technologies Ltd. | 222.08M | -2.40% | 41,234 | 1.80M |
| 289 | KROS | Keros Therapeutics, Inc. | 220.08M | 0.45% | 96,665 | 15.01M |
| 290 | PLX | Protalix BioTherapeutics, Inc. | 217.54M | 3.45% | 257,852 | 80.62M |
| 291 | CAMP | Camp4 Therapeutics Corporation | 216.50M | 0.58% | 56,256 | 4.22M |
| 292 | EVMN | Evommune, Inc. | 215.21M | 2.77% | 579,084 | 10.00M |
| 293 | PYXS | Pyxis Oncology, Inc. | 215.02M | 0.56% | 545,672 | 11.04M |
| 294 | MGNX | MacroGenics, Inc. | 214.67M | 1.81% | 578,082 | 175.14M |
| 295 | ALEC | Alector, Inc. | 213.26M | 1.60% | 1,630,273 | 13.86M |
| 296 | IFRX | InflaRx N.V. | 212.21M | -2.70% | 201,146 | -11.54K |
| 297 | ZNTL | Zentalis Pharmaceuticals, Inc. | 212.07M | -3.45% | 2,034,826 | 26.87M |
| 298 | LRMR | Larimar Therapeutics, Inc. | 207.72M | -4.78% | 1,174,768 | - |
| 299 | PRQR | ProQR Therapeutics N.V. | 204.63M | -1.36% | 784,704 | 21.05M |
| 300 | LYEL | Lyell Immunopharma, Inc. | 200.70M | 2.50% | 324,986 | 27.00K |
| 301 | RNAC | Cartesian Therapeutics, Inc. | 199.08M | 3.79% | 86,784 | 1.48M |
| 302 | IVVD | Invivyd, Inc. | 197.13M | 10.04% | 3,292,938 | 58.37M |
| 303 | CGEN | Compugen Ltd. | 197.03M | 4.00% | 200,016 | 74.00M |
| 304 | STRO | Sutro Biopharma, Inc. | 190.02M | 8.94% | 418,380 | 45.70M |
| 305 | YARW | Yarrow Bioscience, Inc. | 186.09M | 5.82% | 116,857 | - |
| 306 | ELDN | Eledon Pharmaceuticals, Inc. | 184.64M | 0.89% | 582,321 | - |
| 307 | UPB | Upstream Bio, Inc. | 184.58M | -1.46% | 1,285,462 | 3.16M |
| 308 | SION | Sionna Therapeutics, Inc. | 184.47M | -0.24% | 944,434 | - |
| 309 | ACOG | Alpha Cognition Inc. | 184.02M | -2.31% | 225,500 | 15.26M |
| 310 | PEPG | PepGen Inc. | 175.23M | 9.05% | 764,200 | - |
| 311 | NGEN | NervGen Pharma Corp. | 174.19M | 3.51% | 475,279 | - |
| 312 | ORMP | Oramed Pharmaceuticals Inc. | 173.88M | 0.97% | 128,183 | 2.00M |
| 313 | WHWK | Whitehawk Therapeutics, Inc. | 173.31M | 2.36% | 337,395 | 7.15M |
| 314 | TRDA | Entrada Therapeutics, Inc. | 172.35M | 5.05% | 514,662 | 4.69M |
| 315 | DTIL | Precision BioSciences, Inc. | 170.30M | 2.32% | 246,136 | 45.06M |
| 316 | CHRS | Coherus Oncology, Inc. | 165.32M | 1.90% | 1,541,486 | 50.94M |
| 317 | CMPX | Compass Therapeutics, Inc. | 161.48M | 2.01% | 3,339,167 | 850.00K |
| 318 | ADAG | Adagene Inc. | 161.14M | 4.80% | 552,483 | 9.29M |
| 319 | MDWD | MediWound Ltd. | 157.63M | 2.52% | 93,059 | 11.86M |
| 320 | VRXA | Veraxa Biotech AG | 155.55M | -0.90% | 114,458 | 29.54K |
| 321 | NBP | NovaBridge Biosciences | 149.64M | 0.78% | 390,687 | - |
| 322 | CNTN | Canton Strategic Holdings, Inc. | 149.00M | 1.91% | 916,616 | 1.50M |
| 323 | CDXS | Codexis, Inc. | 148.93M | 5.43% | 681,097 | 77.68M |
| 324 | MENS | Jyong Biotech Ltd. | 146.98M | -3.41% | 142,577 | - |
| 325 | MSLE | Satellos Bioscience Inc. | 145.64M | 3.17% | 79,931 | - |
| 326 | MOLN | Molecular Partners AG | 145.45M | - | 66 | 856.30K |
| 327 | TARA | Protara Therapeutics, Inc. | 141.83M | -3.23% | 861,726 | - |
| 328 | ALXO | ALX Oncology Holdings Inc. | 138.28M | 11.77% | 3,709,790 | - |
| 329 | NKTX | Nkarta, Inc. | 138.24M | -4.93% | 1,477,205 | - |
| 330 | AVXL | Anavex Life Sciences Corp. | 137.19M | -0.67% | 1,764,633 | - |
| 331 | KRRO | Korro Bio, Inc. | 137.10M | 4.84% | 440,120 | 2.38M |
| 332 | IPHA | Innate Pharma S.A. | 136.34M | 3.50% | 7,234 | 11.21M |
| 333 | ANTX | AN2 Therapeutics, Inc. | 135.85M | 1.69% | 295,942 | - |
| 334 | TLSA | Tiziana Life Sciences Ltd | 135.77M | - | 264,331 | - |
| 335 | CUE | Cue Biopharma, Inc. | 135.63M | 0.38% | 229,012 | 37.66M |
| 336 | RNA | Atrium Therapeutics, Inc. | 133.60M | 1.69% | 131,235 | 35.84M |
| 337 | VYGR | Voyager Therapeutics, Inc. | 126.93M | 2.49% | 719,348 | 34.46M |
| 338 | HUMA | Humacyte, Inc. | 122.09M | 24.12% | 2,239,880 | 2.12M |
| 339 | OTLK | Outlook Therapeutics, Inc. | 121.72M | 6.34% | 5,348,574 | -1.16M |
| 340 | ABOS | Acumen Pharmaceuticals, Inc. | 120.77M | -4.30% | 602,464 | - |
| 341 | SPRB | Spruce Biosciences, Inc. | 119.19M | 6.39% | 63,772 | 697.00K |
| 342 | NRXP | NRx Pharmaceuticals, Inc. | 117.24M | 4.63% | 1,177,678 | 3.39M |
| 343 | HURA | TuHURA Biosciences, Inc. | 116.62M | 3.98% | 86,690 | - |
| 344 | NERV | Minerva Neurosciences, Inc. | 115.55M | 2.98% | 159,294 | - |
| 345 | ARMP | Armata Pharmaceuticals, Inc. | 114.89M | 11.15% | 20,875 | 5.54M |
| 346 | ENGN | enGene Therapeutics Inc. | 114.60M | 9.62% | 512,274 | - |
| 347 | SEER | Seer, Inc. | 112.96M | -1.92% | 173,288 | 14.22M |
| 348 | FHTX | Foghorn Therapeutics Inc. | 112.24M | 2.16% | 105,514 | 36.74M |
| 349 | LENZ | LENZ Therapeutics, Inc. | 112.17M | 4.08% | 793,842 | 21.48M |
| 350 | MIST | Milestone Pharmaceuticals Inc. | 111.95M | 0.84% | 247,095 | 2.34M |
| 351 | TVGN | Tevogen Inc. | 111.57M | 8.98% | 1,396 | - |
| 352 | CNXU | Conexeu Sciences Inc. | 111.42M | 8.37% | 600,467 | - |
| 353 | GNLX | Genelux Corporation | 111.13M | 6.90% | 796,526 | 8.00K |
| 354 | TNXP | Tonix Pharmaceuticals Holding Corp. | 110.11M | 0.31% | 2,398,134 | 29.10M |
| 355 | INO | Inovio Pharmaceuticals, Inc. | 107.53M | 5.48% | 1,760,062 | 65.34K |
| 356 | VANI | Vivani Medical, Inc. | 103.73M | -0.86% | 19,368 | - |
| 357 | COYA | Coya Therapeutics, Inc. | 101.81M | 3.83% | 236,520 | 8.02M |
| 358 | RTSN | Retension Pharmaceuticals, Inc. | 101.73M | 4.90% | 131,024 | - |
| 359 | KZIA | Kazia Therapeutics Limited | 101.41M | 8.98% | 385,622 | 1.27M |
| 360 | UNCY | Unicycive Therapeutics, Inc. | 100.00M | -2.97% | 229,189 | - |
| 361 | BDTX | Black Diamond Therapeutics, Inc. | 99.97M | 2.35% | 624,814 | 70.00M |
| 362 | PYPD | PolyPid Ltd. | 99.53M | 1.45% | 120,507 | - |
| 363 | CBUS | Cibus, Inc. | 98.59M | -7.86% | 79,314 | 4.35M |
| 364 | PMVP | PMV Pharmaceuticals, Inc. | 97.41M | 4.03% | 376,586 | - |
| 365 | PLYX | Polaryx Therapeutics, Inc. | 97.20M | -1.02% | 42,571 | - |
| 366 | NRXS | NeurAxis, Inc. | 97.20M | 18.53% | 1,126,669 | 5.32M |
| 367 | IMUX | Immunic, Inc. | 96.88M | 6.61% | 285,101 | - |
| 368 | ATRA | Atara Biotherapeutics, Inc. | 96.86M | 0.94% | 24,300 | 6.19M |
| 369 | ANIX | Anixa Biosciences, Inc. | 96.64M | 4.71% | 223,243 | - |
| 370 | ICCC | ImmuCell Corporation | 95.91M | -1.77% | 9,871 | 30.68M |
| 371 | RANI | Rani Therapeutics Holdings, Inc. | 94.79M | 1.46% | 451,360 | 4.88M |
| 372 | PDSB | PDS Biotechnology Corporation | 94.22M | -7.80% | 950,437 | - |
| 373 | TNYA | Tenaya Therapeutics, Inc. | 91.58M | 4.58% | 448,440 | 1.34M |
| 374 | RLYB | Rallybio Corporation | 88.37M | -1.57% | 3,001 | 646.00K |
| 375 | TENX | Tenax Therapeutics, Inc. | 86.50M | -1.63% | 2,012,798 | - |
| 376 | OKUR | OnKure Therapeutics, Inc. | 86.26M | -5.33% | 349,905 | - |
| 377 | AARD | Aardvark Therapeutics, Inc. | 84.48M | -0.52% | 68,596 | - |
| 378 | CLLS | Cellectis S.A. | 83.81M | -1.34% | 101,430 | 63.82M |
| 379 | CRBP | Corbus Pharmaceuticals Holdings, Inc. | 83.75M | -1.81% | 1,089,733 | - |
| 380 | EQ | Equillium, Inc. | 83.70M | 1.54% | 510,931 | 4.39M |
| 381 | NMRA | Neumora Therapeutics, Inc. | 80.23M | 20.45% | 6,460,449 | - |
| 382 | PMN | ProMIS Neurosciences, Inc. | 78.02M | 5.01% | 33,538 | - |
| 383 | PTHS | Pelthos Therapeutics Inc. | 77.56M | 0.05% | 2,482 | 43.30M |
| 384 | TELO | Telomir Pharmaceuticals, Inc. | 77.30M | - | 69,334 | - |
| 385 | NTRB | Nutriband Inc. | 76.22M | -0.79% | 70,178 | 1.62M |
| 386 | CRDF | Cardiff Oncology, Inc. | 75.54M | -0.25% | 454,062 | 508.00K |
| 387 | ACRV | Acrivon Therapeutics, Inc. | 75.42M | 2.33% | 114,417 | - |
| 388 | OKYO | OKYO Pharma Limited | 75.05M | 1.06% | 48,888 | - |
| 389 | HRTX | Heron Therapeutics, Inc. | 71.48M | 4.01% | 1,282,102 | 151.18M |
| 390 | MNOV | MediciNova, Inc. | 71.37M | -1.36% | 58,756 | 920.48K |
| 391 | ONCY | Oncolytics Biotech Inc. | 69.82M | 1.75% | 1,302,329 | - |
| 392 | CGTX | Cognition Therapeutics, Inc. | 69.67M | -5.68% | 77,416 | - |
| 393 | NTHI | NeOnc Technologies Holdings, Inc. | 68.36M | 3.38% | 106,894 | 39.99K |
| 394 | MAIA | MAIA Biotechnology, Inc. | 68.12M | - | 294,964 | - |
| 395 | CSBR | Champions Oncology, Inc. | 66.67M | -0.42% | 9,889 | 60.66M |
| 396 | SPRO | Spero Therapeutics, Inc. | 66.39M | 1.79% | 233,828 | 47.00M |
| 397 | HYFT | MindWalk Holdings Corp. | 65.96M | 2.19% | 11,418 | 11.57M |
| 398 | XBIT | XBiotech Inc. | 65.24M | -0.93% | 85,020 | - |
| 399 | OSTX | OS Therapies Incorporated | 65.04M | 1.44% | 77,153 | - |
| 400 | VRCA | Verrica Pharmaceuticals Inc. | 64.94M | -1.31% | 64,298 | 30.32M |
| 401 | CING | Cingulate Inc. | 63.84M | -3.94% | 175,653 | - |
| 402 | FBIO | Fortress Biotech, Inc. | 63.70M | 0.53% | 219,436 | 68.47M |
| 403 | BMEA | Biomea Fusion, Inc. | 60.63M | 0.29% | 231,293 | - |
| 404 | PLRX | Pliant Therapeutics, Inc. | 60.21M | 10.01% | 481,341 | - |
| 405 | XLO | Xilio Therapeutics, Inc. | 59.35M | 1.35% | 10,368 | 64.09M |
| 406 | GANX | Gain Therapeutics, Inc. | 58.05M | 0.76% | 115,633 | - |
| 407 | CNTB | Connect Biopharma Holdings Limited | 57.07M | -0.31% | 288,109 | 2.95M |
| 408 | ALPS | Alps Group Inc | 56.41M | -3.12% | 10,976 | 3.74M |
| 409 | ACET | Adicet Bio, Inc. | 55.33M | 5.11% | 155,089 | - |
| 410 | GUTS | Fractyl Health, Inc. | 55.18M | 1.96% | 99,569 | 3.00K |
| 411 | ELOX | Eloxx Pharmaceuticals, Inc. | 55.02M | 11.63% | 23,365 | - |
| 412 | GOSS | Gossamer Bio, Inc. | 54.37M | -0.17% | 197,629 | 53.29M |
| 413 | RNTX | Rein Therapeutics Inc. | 54.18M | 7.17% | 1,372,904 | - |
| 414 | RNXT | RenovoRx, Inc. | 53.70M | 6.25% | 328,512 | 1.98M |
| 415 | BOLD | Boundless Bio, Inc. | 53.45M | -1.67% | 181,876 | - |
| 416 | KLRS | Kalaris Therapeutics, Inc. | 52.13M | 2.82% | 56,980 | - |
| 417 | INKT | MiNK Therapeutics, Inc. | 50.72M | -3.96% | 10,095 | - |
| 418 | IBIO | iBio, Inc. | 50.34M | 0.26% | 354,728 | 100.00K |
| 419 | LONA | LeonaBio, Inc. | 49.84M | -1.86% | 35,246 | - |
| 420 | CRBU | Caribou Biosciences, Inc. | 49.82M | 1.00% | 2,881,404 | 10.04M |
| 421 | MREO | Mereo BioPharma Group plc | 49.36M | -0.13% | 529,292 | 500.00K |
| 422 | HYPD | Hyperion DeFi, Inc. | 48.95M | 1.94% | 247,671 | 1.40M |
| 423 | HOWL | Werewolf Therapeutics, Inc. | 48.45M | 1.73% | 426,111 | 21.00M |
| 424 | ATHE | Alterity Therapeutics Limited | 47.33M | -4.27% | 37,481 | 2.50M |
| 425 | ELTX | Elicio Therapeutics, Inc. | 46.78M | -0.56% | 169,348 | - |
| 426 | APLM | Apollomics, Inc. | 46.12M | -3.54% | 4 | 8.84M |
| 427 | CLNN | Clene Inc. | 45.91M | -2.42% | 134,019 | 197.00K |
| 428 | INMB | INmune Bio Inc. | 45.79M | 3.12% | 628,019 | 50.00K |
| 429 | IMA | ImageneBio, Inc. | 45.75M | -2.90% | 21,566 | 800.00K |
| 430 | SER | Serina Therapeutics, Inc. | 45.47M | 4.68% | 27,435 | 130.00K |
| 431 | ANVS | Annovis Bio, Inc. | 44.74M | 2.94% | 50,531 | - |
| 432 | ALDX | Aldeyra Therapeutics, Inc. | 44.48M | -6.72% | 267,712 | - |
| 433 | CELU | Celularity Inc. | 43.16M | 1.53% | 30,597 | 18.97M |
| 434 | DWTX | Dogwood Therapeutics, Inc. | 42.49M | -1.57% | 105,410 | - |
| 435 | VERU | Veru Inc. | 41.60M | 14.55% | 505,327 | 16.89M |
| 436 | TIL | Instil Bio, Inc. | 41.57M | 3.03% | 33,024 | - |
| 437 | GRCE | Grace Therapeutics, Inc. | 41.23M | 3.70% | 109,289 | - |
| 438 | BSEM | BioStem Technologies, Inc. | 37.91M | -3.32% | 102,271 | 34.59M |
| 439 | EXOZ | eXoZymes, Inc. | 37.13M | -13.04% | 24,353 | -700.00 |
| 440 | FLNA | Filana Therapeutics, Inc. | 36.75M | 3.99% | 50,101 | - |
| 441 | LITS | Lite Strategy, Inc. | 36.34M | 2.14% | 317,674 | - |
| 442 | EDSA | Edesa Biotech, Inc. | 36.08M | 0.75% | 75,777 | - |
| 443 | NNVC | NanoViricides, Inc. | 34.97M | 4.58% | 12,934 | - |
| 444 | CRVO | CervoMed Inc. | 34.02M | -1.75% | 200,953 | 331.30K |
| 445 | IRLA | IRulya Therapeutics Inc. | 33.80M | 10.77% | 8,961 | - |
| 446 | ATNM | Actinium Pharmaceuticals, Inc. | 33.33M | 8.76% | 29,445 | 35.09M |
| 447 | ALGS | Aligos Therapeutics, Inc. | 33.03M | 1.15% | 25,466 | 31.52M |
| 448 | BCTX | BriaCell Therapeutics Corp. | 32.85M | 2.03% | 34,463 | - |
| 449 | MGX | Metagenomi Therapeutics, Inc. | 31.93M | -1.87% | 291,419 | 13.56M |
| 450 | GRDX | GridAI Technologies Corp. | 31.58M | 4.94% | 161,489 | - |
| 451 | NXTC | NextCure, Inc. | 31.49M | 4.56% | 72,418 | - |
| 452 | CVM | CEL-SCI Corporation | 30.60M | 1.75% | 72,056 | - |
| 453 | RNAZ | TransCode Therapeutics, Inc. | 30.48M | 4.05% | 35,312 | - |
| 454 | IBO | Impact BioMedical Inc. | 26.98M | -7.20% | 29,032 | 35.00K |
| 455 | ATOS | Atossa Therapeutics, Inc. | 26.45M | -4.68% | 226,636 | - |
| 456 | IGC | IGC Pharma, Inc. | 26.27M | 0.87% | 781,828 | 1.11M |
| 457 | MCRB | Seres Therapeutics, Inc. | 25.41M | 4.55% | 24,613 | 1.88M |
| 458 | PLRZ | Polyrizon Ltd. | 24.31M | -3.84% | 73,310 | - |
| 459 | ABVC | ABVC BioPharma, Inc. | 24.17M | -8.58% | 104,775 | 797.92K |
| 460 | BYSI | BeyondSpring Inc. | 23.93M | -0.87% | 35,064 | 1.88M |
| 461 | EVAX | Evaxion A/S | 23.35M | - | 35,057 | 7.49M |
| 462 | ESLA | Estrella Immunopharma, Inc. | 23.28M | 68.35% | 63,007,203 | - |
| 463 | IMMP | Immutep Limited | 22.76M | -3.55% | 18,732 | 13.79M |
| 464 | CNTX | Context Therapeutics Inc. | 22.10M | -5.91% | 1,337,394 | - |
| 465 | QNTM | Quantum BioPharma Ltd. | 21.92M | 1.88% | 107,393 | - |
| 466 | KYNB | Kyntra Bio, Inc. | 21.70M | -3.68% | 33,168 | 4.62M |
| 467 | AKTX | Akari Therapeutics, Plc | 20.20M | 21.43% | 55,622 | - |
| 468 | COCP | Cocrystal Pharma, Inc. | 19.84M | -0.96% | 11,441 | 330.00K |
| 469 | QNRX | Quoin Pharmaceuticals, Ltd. | 19.12M | -2.93% | 23,692 | - |
| 470 | ATYR | aTyr Pharma, Inc. | 18.03M | 0.27% | 498,675 | 190.00K |
| 471 | NEUP | Neuphoria Therapeutics Inc. | 17.91M | 2.16% | 1,672 | 1.17M |
| 472 | JSPR | Jasper Therapeutics, Inc. | 17.71M | 6.21% | 379,954 | - |
| 473 | PBM | Psyence Biomedical Ltd. | 16.48M | 4.60% | 16,934 | - |
| 474 | NCEL | NewcelX Ltd. | 16.46M | 9.20% | 5,647 | - |
| 475 | TCRX | TScan Therapeutics, Inc. | 16.22M | 13.63% | 878,839 | 7.11M |
| 476 | ICU | SeaStar Medical Holding Corporation | 16.10M | 1.66% | 206,263 | 1.71M |
| 477 | MRKR | Marker Therapeutics, Inc. | 15.34M | 3.35% | 120,792 | 3.55M |
| 478 | KPRX | Kiora Pharmaceuticals, Inc. | 15.34M | -2.43% | 25,393 | 20.00K |
| 479 | DYAI | Dyadic International, Inc. | 15.28M | 2.24% | 508,744 | 3.80M |
| 480 | RADX | Radiopharm Theranostics Limited | 14.56M | -3.57% | 65,871 | 8.90M |
| 481 | DARE | Daré Bioscience, Inc. | 14.56M | 1.51% | 96,943 | 1.37M |
| 482 | TVRD | Tvardi Therapeutics, Inc. | 14.27M | 7.00% | 94,575 | - |
| 483 | CNSY | Cerenome, Inc. | 14.27M | 11.24% | 111,758 | 4.20M |
| 484 | BCDA | BioCardia, Inc. | 14.21M | 1.22% | 236,273 | 3.00K |
| 485 | LPCN | Lipocine Inc. | 13.85M | -0.59% | 267,172 | 1.57M |
| 486 | KTTA | Pasithea Therapeutics Corp. | 13.70M | 0.17% | 5,445 | - |
| 487 | HIND | Vyome Holdings, Inc. | 13.41M | -1.04% | 14,989 | 129.73K |
| 488 | GTBP | GT Biopharma, Inc. | 13.28M | 18.52% | 62,941 | - |
| 489 | ALLR | Allarity Therapeutics, Inc. | 13.25M | -4.65% | 323,178 | 345.00K |
| 490 | CTXR | Citius Pharmaceuticals, Inc. | 12.63M | -1.08% | 305,369 | 7.11M |
| 491 | AEON | AEON Biopharma, Inc. | 12.12M | 6.16% | 24,769 | - |
| 492 | ACTU | Actuate Therapeutics, Inc. | 12.00M | 15.13% | 472,091 | - |
| 493 | PTN | Palatin Technologies, Inc. | 11.92M | -12.53% | 43,339 | 13.19M |
| 494 | INAB | IN8bio, Inc. | 11.68M | -1.25% | 9,826 | - |
| 495 | ENSC | Ensysce Biosciences, Inc. | 11.63M | 6.58% | 331,719 | 4.50M |
| 496 | PLUR | Pluri Inc. | 11.60M | 1.08% | 317 | 1.02M |
| 497 | PASG | Passage Bio, Inc. | 11.58M | -1.64% | 2,689 | - |
| 498 | CLRB | Cellectar Biosciences, Inc. | 11.25M | 0.85% | 382,260 | - |
| 499 | INTS | Intensity Therapeutics, Inc. | 11.04M | -1.17% | 8,343 | - |
| 500 | PHIO | Phio Pharmaceuticals Corp. | 10.76M | -2.51% | 135,782 | - |